Jakubowska, Anna

Selected publications

Two truncating variants in FANCC and breast cancer risk. Scientific Reports. 2019 Academic Article GET IT
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics. 2019 Academic Article GET IT
Times cited: 57
A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nature Genetics. 2018 Academic Article GET IT
Times cited: 18
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics. 2017 Academic Article GET IT
Times cited: 69
Association analysis identifies 65 new breast cancer risk loci. Nature. 2017 Academic Article GET IT
Times cited: 211
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. European Journal of Human Genetics. 2017 Academic Article GET IT
Times cited: 7
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. Nature Genetics. 2017 Academic Article GET IT
Times cited: 66
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Research and Treatment. 2017 Academic Article GET IT
Times cited: 9
Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer Research. 2016 Academic Article GET IT
Times cited: 13
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 2016 Academic Article GET IT
Times cited: 24
Age-And tumor subtype-specific breast cancer risk estimates for CHEK2∗1100delC Carriers. Journal of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 62
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Research. 2016 Academic Article GET IT
Times cited: 13
An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment. 2016 Academic Article GET IT
Times cited: 11
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. 2016 Review GET IT
Times cited: 8
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nature Communications. 2016 Academic Article GET IT
Times cited: 38
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature Genetics. 2016 Review GET IT
Times cited: 53
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Fertility and Sterility. 2016 Academic Article GET IT
Times cited: 13
Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research. 2016 Academic Article GET IT
Times cited: 33
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 2016 Academic Article GET IT
Times cited: 43
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research. 2015 Academic Article GET IT
Times cited: 13
Assessing associations between the AURKAHMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers. PLoS ONE. 2015 Academic Article GET IT
Times cited: 11
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA - Journal of the American Medical Association. 2015 Academic Article GET IT
Times cited: 179
Candidate genetic modifiers for breast and ovarian cancer risk inBRCA1andBRCA2 mutation carriers. Cancer Epidemiology Biomarkers and Prevention. 2015 Academic Article GET IT
Times cited: 14
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Human Molecular Genetics. 2015 Academic Article GET IT
Times cited: 20
Fine-scale mapping of the 4q24 locus identifies & pr two Independent loci associated with breast cancer risk. Cancer Epidemiology Biomarkers and Prevention. 2015 Academic Article GET IT
Times cited: 15
Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 2015 Review GET IT
Times cited: 133
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. American Journal of Human Genetics. 2015 Academic Article GET IT
Times cited: 17
Prediction of breast cancer risk based on profiling with common genetic variants. Journal of the National Cancer Institute. 2015 Academic Article GET IT
Times cited: 218
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research. 2014 Academic Article GET IT
Times cited: 25
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: A large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Research. 2014 Academic Article GET IT
Times cited: 40
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. PLoS Genetics. 2014 Academic Article GET IT
Times cited: 22
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 2013 Academic Article GET IT
Times cited: 348
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk. PLoS Genetics. 2013 Academic Article GET IT
Times cited: 169
Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk. PLoS Genetics. 2013 Academic Article GET IT
Times cited: 75
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Breast Cancer Research and Treatment. 2012 Academic Article GET IT
Times cited: 2
Comparison of 6q25 breast cancer hits from Asian and European genome wide association studies in the Breast Cancer Association consortium (BCAC). PLoS ONE. 2012 Academic Article GET IT
Times cited: 44
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology Biomarkers and Prevention. 2012 Academic Article GET IT
Times cited: 14
Associations of common variants at 1p11.2 and 14q24.1 (RAD51l1) with breast cancer risk and heterogeneity by tumor subtype: Findings from the Breast Cancer Association Consortium. Human Molecular Genetics. 2011 Academic Article GET IT
Times cited: 59
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Human Genetics. 2011 Academic Article GET IT
Times cited: 12
Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. PLoS Biology. 2011 Academic Article GET IT
Times cited: 52
Associations of breast cancer risk factors with tumor subtypes: A pooled analysis from the breast cancer association consortium studies. Journal of the National Cancer Institute. 2011 Review GET IT
Times cited: 423
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 2011 Academic Article GET IT
Times cited: 31
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature Genetics. 2010 Academic Article GET IT
Times cited: 234
RAD51 135G→C modifies breast cancer risk among BRCA2 mutation carriers: Results from a combined analysis of 19 studies. American Journal of Human Genetics. 2007 Academic Article GET IT
Times cited: 192
AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A Consortium of Investigators of Modifiers of BRCA1/2 study. Cancer Epidemiology Biomarkers and Prevention. 2007 Academic Article GET IT
Times cited: 26

VIVO Weill Cornell Medical College

Jakubowska, Anna External Author

Publications

Selected publications